198 related articles for article (PubMed ID: 24458359)
1. Cdc2-like kinase 2 suppresses hepatic fatty acid oxidation and ketogenesis through disruption of the PGC-1α and MED1 complex.
Tabata M; Rodgers JT; Hall JA; Lee Y; Jedrychowski MP; Gygi SP; Puigserver P
Diabetes; 2014 May; 63(5):1519-32. PubMed ID: 24458359
[TBL] [Abstract][Full Text] [Related]
2. Exercise decreases CLK2 in the liver of obese mice and prevents hepatic fat accumulation.
Muñoz VR; Gaspar RC; Kuga GK; Nakandakari SCBR; Baptista IL; Mekary RA; da Silva ASR; de Moura LP; Ropelle ER; Cintra DE; Pauli JR
J Cell Biochem; 2018 Jul; 119(7):5885-5892. PubMed ID: 29575149
[TBL] [Abstract][Full Text] [Related]
3. Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis.
Rodgers JT; Haas W; Gygi SP; Puigserver P
Cell Metab; 2010 Jan; 11(1):23-34. PubMed ID: 20074525
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation.
Liu Y; Ma Z; Zhao C; Wang Y; Wu G; Xiao J; McClain CJ; Li X; Feng W
Toxicol Lett; 2014 Apr; 226(2):117-23. PubMed ID: 24503013
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression.
Estall JL; Kahn M; Cooper MP; Fisher FM; Wu MK; Laznik D; Qu L; Cohen DE; Shulman GI; Spiegelman BM
Diabetes; 2009 Jul; 58(7):1499-508. PubMed ID: 19366863
[TBL] [Abstract][Full Text] [Related]
6. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
[TBL] [Abstract][Full Text] [Related]
7. Gly482Ser mutation impairs the effects of peroxisome proliferator-activated receptor γ coactivator-1α on decreasing fat deposition and stimulating phosphoenolpyruvate carboxykinase expression in hepatocytes.
Chen Y; Mu P; He S; Tang X; Guo X; Li H; Xu H; Woo SL; Qian X; Zeng L; Wu C
Nutr Res; 2013 Apr; 33(4):332-9. PubMed ID: 23602251
[TBL] [Abstract][Full Text] [Related]
8. The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase.
Viswakarma N; Jia Y; Bai L; Gao Q; Lin B; Zhang X; Misra P; Rana A; Jain S; Gonzalez FJ; Zhu YJ; Thimmapaya B; Reddy JK
J Biol Chem; 2013 Sep; 288(39):27898-911. PubMed ID: 23943624
[TBL] [Abstract][Full Text] [Related]
9. PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion.
Morris EM; Meers GM; Booth FW; Fritsche KL; Hardin CD; Thyfault JP; Ibdah JA
Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(8):G979-92. PubMed ID: 22899824
[TBL] [Abstract][Full Text] [Related]
10. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice.
Burgess SC; Leone TC; Wende AR; Croce MA; Chen Z; Sherry AD; Malloy CR; Finck BN
J Biol Chem; 2006 Jul; 281(28):19000-8. PubMed ID: 16670093
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats.
Benton CR; Holloway GP; Han XX; Yoshida Y; Snook LA; Lally J; Glatz JF; Luiken JJ; Chabowski A; Bonen A
Diabetologia; 2010 Sep; 53(9):2008-19. PubMed ID: 20490453
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
[TBL] [Abstract][Full Text] [Related]
13. The role of proliferator-activated receptor gamma coactivator-1alpha in the fatty-acid-dependent transcriptional control of interleukin-10 in hepatic cells of rodents.
Morari J; Torsoni AS; Anhê GF; Roman EA; Cintra DE; Ward LS; Bordin S; Velloso LA
Metabolism; 2010 Feb; 59(2):215-23. PubMed ID: 19766270
[TBL] [Abstract][Full Text] [Related]
14. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response.
Potthoff MJ; Inagaki T; Satapati S; Ding X; He T; Goetz R; Mohammadi M; Finck BN; Mangelsdorf DJ; Kliewer SA; Burgess SC
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10853-8. PubMed ID: 19541642
[TBL] [Abstract][Full Text] [Related]
15. Daytime restricted feeding modifies the daily regulation of fatty acid β-oxidation and the lipoprotein profile in rats.
Rivera-Zavala JB; Molina-Aguilar C; Pérez-Mendoza M; Olguín-Martínez M; Hernández-Muñoz R; Báez-Ruiz GA; Díaz-Muñoz M
Br J Nutr; 2017 Apr; 117(7):930-941. PubMed ID: 28482939
[TBL] [Abstract][Full Text] [Related]
16. Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.
Buler M; Aatsinki SM; Skoumal R; Komka Z; Tóth M; Kerkelä R; Georgiadi A; Kersten S; Hakkola J
J Biol Chem; 2012 Jan; 287(3):1847-60. PubMed ID: 22117073
[TBL] [Abstract][Full Text] [Related]
17. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
18. PGC-1
Gudiksen A; Pilegaard H
Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28400503
[TBL] [Abstract][Full Text] [Related]
19. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
20. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
